Keeping in line with similar actions taking place today, Valkyrie has filed a registration of securities with the US Securities and Exchange Commission (SEC) for its Spot Bitcoin ETF. Indeed, the filing shows a trend, with Fidelity, Grayscale, and VanEck doing the same.
The filing was made official today and increases the likelihood that a host of approvals will be issued early next week. Valkyrie is one of more than a dozen applicants seeking to issue the first Spot Bitcoin ETF in the United States.
Also Read: Goldman Sachs Wants Role in BlackRock, Grayscale Bitcoin ETF
Valkyrie Files Crucial Registration With SEC Ahead of Spot Bitcoin ETF Decision
Over the last several months, the potential approval of a Spot Bitcoin ETF in the United States has excited the market. Indeed, a lot of applicants are seeking to issue the investment product that would be a landmark moment for the sector in the country. Despite rumblings of potential rejection, various filings today seem to point to a much different decision.
Now, Valkyrie has filed a registration of securities with the SEC for its pending Spot Bitcoin ETF. The development should signal a plethora of approvals to come in next week. Moreover, it was repeated by other issues, including Fidelity, Grayscale, and VanEck. There are expected to be several other prospective issuers that make similar filings in the coming days.
Also Read: SEC & Exchanges Meet for Final Comments on Spot Bitcoin ETFs
The industry is expecting such approvals to become public between January 8th and the 10th. Moreover, various firms are already seeking to be a part of the ETFs that are approved. Among them is none other than Goldman Sachs. Specifically, the financial institution is seeking the crucial role of AP for Grayscale and BlackRock ETFs.
Although nothing is official, the week has been filled with positive steps. Meetings between the SEC and exchanges Nasdaq, the New York Stock Exchange, and Cboe also fortify that message. The trajectory appears to fall in line with wider industry expectations, as approval could come as early as Monday.